Stay updated on Dapagliflozin Effects on Heart in Diabetes Clinical Trial

Sign up to get notified when there's something new on the Dapagliflozin Effects on Heart in Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dapagliflozin Effects on Heart in Diabetes Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now shown and the prior funding-status notice (v3.4.1) has been removed; no trial data, eligibility criteria, or results were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T04:56:54.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A government funding lapse notice appears on the page, and the revision number has been updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T04:33:49.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The changes are minor UI/metadata updates: a glossary toggle is shown, the QC status label now reads 'Last Update Submitted that Met QC Criteria', the 'No FEAR Act Data' note was removed, and the study revision updated from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T02:59:55.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page shows a minor revision update: Revision: v3.3.4 added and Revision: v3.3.3 removed, which does not alter study details or eligibility information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:11:29.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Footer updates include Revision: v3.3.3 and removal of the HHS Vulnerability Disclosure link and Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T09:27:02.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Page shows a revision reference updated from v3.3.1 to v3.3.2; there are no visible changes to study details or layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T16:55:28.000Z thumbnail image

Stay in the know with updates to Dapagliflozin Effects on Heart in Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dapagliflozin Effects on Heart in Diabetes Clinical Trial page.